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Non-covalent complexes between three derivitized cyclodextrins (CD’s) and six local anes-
thetics were studied using capillary electrophoresis (CE) and electrospray ionization mass
spectrometry (ESI-MS). The CE study was performed using the complete filling technique
(CFT). A comparison between the migration data from CE and ESI-MS inclusion complex peak
abundances was made representing the association between local anesthetics and CD’s in the
solution and the gas phase, respectively. The results from this study showed comparable
behavior of the complexes in the CE and mass spectrometer, indicating similarity in the
parameters controlling the stability of these complexes. Therefore, the formation of specific
non-covalent complexes, as shown in this study, could be used to predict the behavior of a
complexing agent with a substrate in the solution phase by observing data obtained from
ESI-MS. (J Am Soc Mass Spectrom 2002, 13, 928–935) © 2002 American Society for Mass
Spectrometry
The formation of specific non-covalent complexesby association of guest compounds within thecavity of host molecules is currently an area of
great interest in the field of mass spectrometry. Most
cyclodextrins (CD’s) are made up of six, seven, or eight
glucose monomers bound together by a 1,4 ether link-
age. Cyclodextrins are gaining importance in asymmet-
ric organic synthesis for their catalytic properties and in
the pharmaceutical, cosmetic, agriculture, and food
industries where their ability to improve the hydrophi-
licity of lipophilic compounds is of great importance [1].
Understanding the formation of these non-covalent
complexes with CD’s would assist in improving our
understanding of this important interaction. Capillary
electrophoresis (CE) and electrospray ionization mass
spectrometry (ESI-MS) are two techniques that can be
used together to give a comprehensive picture of the
formation of these complexes.
Mass spectrometry has been a powerful tool in the
study of non-covalent interactions. Electrospray ioniza-
tion is a soft ionization technique, which therefore allows
for the transfer of non-covalent complexes from the solu-
tion phase into the gas phase. The gas phase environment
of the mass spectrometer has the advantage of avoiding
many interferences and allows for facile identification and
detection of host–guest complexes [2]. Numerous studies
have reported the observation of intact non-covalent
complexes and this information was used to provide
insight into specific non-covalent associations in solu-
tion [1–6]. However, the production of non-specific
adducts have been reported too, leading to concerns
over the ability of mass spectrometry to be used to
study non-covalent associations [7, 8].
If the ESI-MS is able to retain specific inclusion
complexes in the same form as in the solution state, it
could be a very effective tool to study the formation of
these complexes [1, 8, 9]. Since ESI-MS can be applied to
solution conditions close to those of physiological inter-
est, it can provide information on enzyme–substrate,
receptor–ligand and antigen–antibody interactions, as
well as host–guest complexes [2, 10].
The correlation between the behavior of solution and
gas phase complexes has been studied extensively over
the past decade. Several approaches have been pro-
posed to determine if the gas phase complex in question
is a non-specific adduct or representative of a specific
non-covalent interaction. The first approach was devel-
oped by Vouros and co-workers where substrates that
lack the structural features favoring association with a
complexing agent are compared to substrates that favor
the formation of such complexes. In this case, the
detection of any complexes would indicate the forma-
tion of electrostatic adducts during the electrospray
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process [7]. These weakly bound complexes would also
decompose easily using low energy collision induced
dissociation studies (CID) [11]. Second, hydrogen/deu-
terium (H/D) exchange has been used by comparing
the average number of exchanges for the individual
units comprising the complex with the average number
of exchanges for the complex itself. If a complex is
formed during the ionization process, the average num-
ber of H/D atoms exchanged in a complex should equal
the sum of H/D atoms exchanged in each of the
components [12]. Third, an on-line separation technique
like gel permeation was applied to remove the free
guest and the free complexing agent from the specific
complex in solution. This technique guarantees that
neither the guest nor the host is found free in the
solution to form non-specific adducts during ionization
[13]. The fourth approach involves masking or unfold-
ing an active site that is known to bind specifically to
the complexing agent. If the detected complex still
exists after the deconformation of the active site, it
indicates formation of non-specific aggregates [10].
A previous study performed in this lab showed the
formation of specific non-covalent complexes of a
group of acidic hypnotic agents [3]. In this study, we
extend this approach to a group of basic local anesthet-
ics in an attempt to determine whether the behavior
previously observed was limited to the acidic com-
pounds or is more universal in its applicability.
The six local anesthetics under study have structural
features that favor binding with the CD cavity in
ammonium formate buffer. Ammonium formate was
chosen because of earlier reports that it suppresses the
formation of non-specific aggregates in positive ion
electrospray [13]. To show the correlation between the
behavior of specific non-covalent complexes in the
liquid and the gas phase, this study is divided into two
parts. First, the comparison of the order of association
constants of the different analytes with each CD as
measured by CE, with the order of their peak intensity
ratios as measured by ESI-MS. Second, comparing the
relative affinities of each analyte to three different
complexing agents (CD’s) as calculated by CE and
ESI-MS. If the behavior of the solution phase and the
gas phase complexes are similar, there is evidence for
formation of specific non-covalent inclusions.
Experimental
Materials and Reagents
Proparacaine, meprilcaine, lidocaine, prilocaine, dibu-
caine, dyclonine, heptakis(2,3,6-tri-o-methyl)--cyclo-
dextrin, heptakis(2,6-di-o-methyl)--cyclodextrin, and
ammonium formate 97% were obtained from Aldrich
Chemical Company, Inc. (Milwaukee, WI). Formic acid
90.3% was obtained from J. T. Baker (Phillipsburg, NJ).
Nylon membrane syringe filters (0.2 m) were pur-
chased from Fisher Scientific (Pittsburgh, PA). Methyl-
-cyclodextrin (MCD), hydroxypropyl--cyclodextrin,
and -cyclodextrin were kindly supplied by Cerastar
USA, Inc. (Indianapolis, IN)
Mass Spectrometry
A Quattro II (Micromass, Inc., Beverly, MA) triple
quadrupole mass spectrometer equipped with the
Z-spray electrospray ionization source was used for all
the mass spectrometry experiments. The mass spec-
trometer was set to the positive ion mode of operation,
with the source temperature at 150°C. The cone and the
ion source capillary voltages were adjusted to maximize
the signal/noise ratio of the analyte–CD complex,
which were found to be 20 V and 3000 V, respectively.
The data were collected in the multi-channel analysis
(MCA) mode and represent the summation of ten
individual mass spectral scans. Direct flow injection
was carried out using a syringe infusion pump (KD
Scientific, Boston, MA) to deliver sample at a flow rate
of 15 L/min into the ESI source.
Capillary Electrophoresis
A P/ACE system 5000 CE (Beckman, Inc., Fullerton,
CA) equipped with an UV detector was used for all CE
experiments. The separation capillary was uncoated
fused-silica tubing (Polymicro Technologies, Phoenix,
AZ) of 75 m i.d.. The total length of the capillary was
57 cm with a 50 cm effective length, which represents
the distance from the front of the capillary to the
detector. The capillary was thermostated at 25°C and
detection was carried out using the UV detector at 254
nm. Samples were introduced into the capillary by
pressure, 0.5 psi (3.4 kPa), for 5 s. Separation was found
to be optimum at 15 kV toward the cathodic electrode.
Electrolyte backgrounds (EBG) over the cyclodextrin
concentration range from 14–60 mM were prepared in
100 mM ammonium formate buffer pH 2.
Preparation of Stock and Standard Solutions
For the CE experiments the buffer system was prepared
as 100 mM ammonium formate in water, which was
then adjusted to pH 2 using concentrated formic acid.
The analytes were dissolved in 10-fold diluted ammo-
nium formate buffer (10 mM) to prepare 1 mg/ml stock
solutions. Fifty g/ml samples concentrations were
then prepared from each respective stock to be injected
into the CE. Dissolving the analyte in a solvent of lower
conductivity (lower concentration) will cause them to
be stacked in a narrower zone, producing sharper peaks
and allowing for lower limits of detection. Cyclodextrin
(CD) stock solutions were prepared in the 100 mM
ammonium formate to give a final concentration range
from 14–60 mM. All solutions were filtered prior to use
with a 0.2 m Nylon filter syringe.
For the MS experiments, 20 mg/ml cyclodextrin
stock solutions were prepared in 100 mM ammonium
formate buffer. Analyte stock solutions were prepared
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in the same way as for the CE. Appropriate volumes of the
CD stock and the analyte stock solution were pipetted
to give 1:100 w/w ratio of the analyte to the CD.
Electrophoretic Conditions
Initially an uncoated fused silica capillary was rinsed
with 1 M HCl for 2 h, with water for 3 h, with 0.1 M
NaOH for 30 min, and finally with water for 30 min.
The capillary was flushed with water, running buffer,
and with water again, 2 min each before the buffered
CD solution was introduced into the capillary. The
buffer system was 100 mM ammonium formate (pH 2).
The buffer in the outlet and inlet vials was replaced
after each run to avoid ion depletion allowing better
reproducibility of the analytes migration times. The
ammonium formate buffer was prepared fresh every
morning and the capillary was stored dry overnight.
The principle of analyte stacking was applied to this
study by dissolving the analyte in a solvent of lower
conductivity than the run buffer. The electric current
increases by decreasing the solvent conductivity, which
causes the analyte to move faster in the sample plug
until encountering the boundary of the higher concen-
tration buffer [3, 14]. This approach causes the analyte
to be stacked in a narrow zone producing sharper peaks.
Figure 1 shows a representative electropherogram.
The Complete Filling Technique (CFT)
For all CE experiments in this study the complete filling
technique (CFT) was used. The CFT was developed as a
modification of the partial filling technique (PFT). The
PTF was introduced by Valtcheva et al. in 1993 [15],
modified by Tanaka and Terabe, in 1995 [16], and
applied by Amini et al. in 1997 [17] and again in 1999
[18]. In the PFT, the capillary is filled with the selector
solution up to the detection window, the sample injec-
tion is then applied, and finally the separation process is
pursued by applying the voltage while the capillary
ends are dipped into the electrolyte background (EBG)
containing no CD selector [14, 17–20]. The PFT was
originally developed to avoid detection interferences by
a UV active selector by choosing separation conditions
that held the selector stationary or moving away from
the detection window [19, 20]. Since the selector used in
this study (cyclodextrin) has no UV interference or low
UV absorbtivity, the capillary can be entirely filled with
the CD solution prior to sample introduction. The
separation was performed in the plain EBG [18]. The
use of the CFT significantly decreases the consumption
of the cyclodextrin selector used (this whole study was
conducted using milligrams of CD), which is of great
importance when expensive selectors are used.
When using the PFT, a separation zone of a specific
Figure 1. Typical electropherogram showing the resolution of the six local anesthetics, proparacaine
(11.14), lidocaine (16.68), prilocaine (17.44), meprilcaine (18.62), lidocaine (20.20), and dyclonine
(23.36), on a 50 cm, 75 m uncoated silica capillary. The buffer contained 33.3 mM MCD in 100 mM
ammonium formate buffer (pH 2) with detection at 254 nm. The separation voltage was 15 kV.
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length is used by applying the CD selector solution with
a low pressure for a specific amount of time. This
method is usually very time consuming [18]. We chose
to use CFT rather than PFT, since (1) previous studies
indicate that the longer the separation zone the better
the resolution [18, 19], and (2) the CD selector is
UV-inert. The capillary was flushed with the CD solu-
tion using high pressure for 2 min, which guarantees
complete filling of the whole capillary length. The
voltage was applied after the sample was introduced
into the capillary, and the capillary ends are dipped in
the input and the output vials filled with the EBG
containing no CD selector.
Results and Discussion
Six local anesthetics have been studied; their structures
and pKa values are shown in Figure 2. Ammonium
acetate, monobasic sodium phosphate and ammonium
formate buffer systems were investigated to separate
the local anesthetics. Figure 1 illustrates a representa-
tive electropherogram where the analytes were sepa-
rated in formate buffer containing 33.3 mM MCD.
Ammonium formate at pH 2 was found to provide the
sharpest peaks with the best chiral resolution of the
single chiral analyte, prilocaine. Acidic pH was found to
provide improved CE separations because it was able to
ionize the basic analytes. It was noticed that CE resolu-
tion increased with decreasing pH. Some of the peaks
were partially overlapped and base line resolution of all
the peaks was not achieved until we went down to pH
2. At pH 2, the electroosmotic flow (EOF) is almost
totally suppressed, the analytes are all positively
charged and the neutral CD’s are almost immobile. The
uncomplexed positively charged analyte moves toward
the cathodic end (detector end) by its own native
electrophoretic velocity. The greater the interaction with
the CD the longer the migration time of the analyte [21].
MCD, heptakis-di-o-methyl, and tri-o-methyl--CD
were studied over the concentration range of 10–80
mM. The relationship between the migration time and
the CD concentration was linear over the range from
15–65 mM. All three CD’s were able to separate the six
analytes. However, base line resolution of the enanti-
omers of prilocaine was achieved when using heptakis
di-o-methyl--CD and MCD at concentrations greater
than 50 mM.
Calculation of the Local Anesthetic-CD Interaction
by CE and ESI-MS
To determine the extent of complexation or association
between the CD selector and the analyte (local anes-
thetic) in the solution phase, the association constant (K)
was determined. K values were calculated using the
general equation of micellar electrokinetic capillary
chromatography (MECC). This equation expresses the
relationship between the apparent velocity of the com-
plex and the apparent velocity of the free analyte and
the free CD [22]:
Vobs  Faq(Vapp.A) Fmc(Vapp.mc) (1)
Where Vob is equal to the observed complex velocity,
VappA is equal to the apparent drug velocity in the CD
free buffer, Vappmc is equal to the apparent CD velocity
in the drug free buffer and Faq, Fmc are equal to the
molar fraction factor of the free drug in solution (naq/
ntotal) and drug complexed with the CD (nmc/ntotal)
respectively. The association constant (K) can be deter-
mined using the following eq [22]:
KC nmc/naq (2)
Where C is the CD concentration and nmc/naq is the
molar fraction of the complexed drug to the uncom-
plexed drug. The following equation expresses the
relationship between the net analyte velocity (Vapp), the
electrophoretic velocity (Vep), and the electroosmotic
velocity (Veo) [22]:
Figure 2. Chemical structures of the local anesthetics.
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Vapp  Vep  Veo (3)
By substituting eq 2 and eq 3 into eq 1, we are able to
express the velocity of the analyte–CD complex in terms
of the association constant, CD concentration, and elec-
trophphoretic velocity of uncomplexed species [22]:
Vob  (1/1 KC)(Vep.a  Veo) (K C/K C 1)
 (Vep.mc  Veo) (4)
Since pH 2 was used, which is low enough to suppress
the electroosmotic flow by not allowing enough depro-
tonation or ionization of the silinol groups that form the
internal surface of the capillary, the Veo term equals
zero [21, 23, 24]. This condition was proven by using a
neutral marker that was not observed by the UV
detector following 5 h of analysis time. Vepmc also
equals zero since all the CD’s used are neutral. Apply-
ing these conditions to eq 4, we can simplify it to eq 5:
Vob  (1/1 KC)(Vapp.a) (5)
The relationship between the velocity and the migration
time is [22]:
V L/T (6)
Where L is the total capillary length and T is the
apparent migration time. Substituting eq 6 into eq 5
yields an equation, which relates observed migration
times to CD concentration:
Tobs  Tapp.AKC Tapp.A (7)
Where Tob is equal to the migration time observed in the
presence of the CD, TappA is equal to the observed
migration time in the absence of the CD.
By plotting the Tobs on the y-axis versus C in the
x-axis and by dividing the slope by TappA we were able
to calculate the association constant values (K) for all
the local anesthetics with the CD’s. The results are
shown in Table 1. In ESI-MS the extent of complexation
can be determined by calculating the CD fraction com-
plexed with the analyte by measuring the ratio of
CD–analyte complex peak height to the sum of the
complexed and the free CD (Rms) [4, 5]: Rms  CD–
analyte complex peak height/CD–analyte complex
peak height  free CD peak height. Higher Rms values
indicate stronger analyte–CD association, therefore Rm
is a measure of the strength of the association.
Mass Spectrometry Data
MCD and heptakis di-methoxy--CD have a distribu-
tion of peaks in the mass spectrum separated by 14
mass units difference representing different degrees of
substitution of the methyl groups. Each CD–analyte
complex peak height was divided by the corresponding
free CD peak height and the average for each set was
used to calculate Rms. The standard conditions to com-
pare complex intensities of different analytes would be
to apply the same CD with all the analytes in the same
injection, thus creating a competitive environment for
the different substrates to compete for binding to the
CD each according to its own relative affinity. Unfortu-
nately, lidocaine (235.5 Da) and meprylcaine (236.5 Da)
have almost the same molecular weight, differing by
one mass unit. Furthermore, prilocaine (221.5 Da) is 14
mass units lower than lidocaine which is the exact mass
difference between the peaks corresponding to the
degree of methylation of the CD. It was therefore not
possible to measure Rms values for the six analytes in
Table 1. Association constant values (K) as calculated from CE and normalized complexs intensities values (n.Rms) averages
MCD Heptakis-di-o-methyl--CD Heptakis-tri-o-methyl--CD
CE (K) ESI-MS (n.Rms) CE ESI-MS (n.Rms CE ESI-MS (n.Rms)
Proparacaine 1.55 0.549 0.784 0.513 0.738 0.215
Lidocaine 1.82 0.743 1.16 0.591 0.779 0.310
Prilocaine 1.95 0.849 1.98 0.677 0.784 0.397
Meprilcaine 2.28 0.915 2.83 0.752 0.816 0.541
Dibucaine 4.23 1 4.20 1 1.50 1
Dyclonine 4.26 2.450 4.23 1.401 1.88 4.430
Note: All complex intensities values were normalized to the responses from dibucaine.
Figure 3. Mass spectrum of a mixture of prilocaine, dibucaine,
and MCD in 100 mM ammonium formate buffer (pH 2). The
peaks marked “A” represent signals from free MCD. The peaks
marked “P” represent CD–prilocaine complexes and the peaks
marked “D” represent various CD–dibucaine complexes.
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the same injection using our quadrupole instrument,
because of the overlap of the peaks in the mass spectra.
In order to simulate a partial competitive environment
as much as possible, five injections of each analyte with
the CD were run. A representative mass spectrum is
shown in Figure 3. Each injection contained dibucaine,
which has the highest molecular weight and therefore
does not overlap with any other analyte peaks, and one
other local anesthetic. By normalizing each drug com-
plex peak intensity to the peak intensity of the dibu-
caine complex, it was possible to calculate relative Rms
values normalized to the dibucaine peak intensity. Each
individual injection was repeated three times and the
average was considered for the data in Tables 2, 3, and
4. The Rms data have standard deviations of less than
11% indicating the high reproducibility of the ESI-MS
data. Proparacaine, however, shows a high standard
deviation for its Rms values which is most likely due to
the fact that it has a relatively low affinity to the CD’s.
It is also interesting to note that the measured Rms
values do not differ because of the number of methyl
side chains in the CD’S.
The second part of the study was to compare the
relative affinities of each analyte separately, between
the three CD’s used. The standard conditions would
normally be to apply the analyte with the three CD’s
together in a single injection again creating a competi-
tive environment between the analytes and the CD’s.
Since the mass distributions of MCD and heptakis-di-
methoxy--CD were overlapping, it was not possible to
create such an environment. Again the alternative was
to create a partially competitive environment where
(MCD and heptakis-tri-methoxy--CD) and (heptakis-
tri and di-methoxy--CD) were run as separate injec-
tions with each analyte.
By normalizing the height of MCD-drug complex
peak to the heptakis-tri-methoxy--CD and doing the
same to heptakis-di-methoxy--CD, it was possible to
calculate a relative Rms for each CD normalized to
heptakis-tri-methoxy--CD with the heptakis-tri-me-
thoxy--CD normalized K equal to one. These normal-
ized values are shown in Table 5.
Formation of Specific Local Anesthetic-CD Non-
Covalent Complexes
An interesting feature of the ESI-MS binding of the
analytes with the cyclodextrins is the reproducible loss
of water molecule. This water loss is presumed to arise
from displacement of water from the CD cavity. This
water loss was not observed in our earlier studies with
the bindings of barbiturates with CD’s. However, that
study did not use the same CD’s and was conducted at
a much higher pH. It is not known if this loss of water
is involved in the solution state interactions between the
local anesthetics and the CD’s.
All the local anesthetics chosen have structural fea-
tures that favor binding with the -CD cavity. Previ-
ously, the formation of true host–guest inclusion com-
Table 2. Normalized complex intensities values (n.Rms) of the analytes with MCD as calculated from the ESI-MS data
CD Proparacaine Lidocaine Prilocaine Meprilcaine Dibucaine Dyclonine
m/z m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms
1376 1653 0.810 1593 0.716 1579 0.782 1594 0.916 1702 1 1648 —
1390 1667 0.383 1607 0.775 1593 0.843 1608 0.910 1716 1 1662 2.501
1404 1681 0.558 1621 0.757 1607 0.885 1622 0.853 1730 1 1676 2.398
1418 1695 0.444 1635 0.724 1621 0.886 1636 0.980 1744 1 1690 —
Average 0.549 0.743 0.849 0.915 1 2.45
RSDa 31.77 5.31 7.69 6.11 1 2.51
Note: Not all data points were available due to the overlap of the signal. This is indicated by (—). All complex intensities values were normalized to
the responses from dibucaine.
aTo calculate RSD values, data from the three trials were considered.
Table 3. Normalized complex intensities values (n.Rms) of the analytes with heptakis-di-o-methyl--CD as calculated
from the ESI-MS data
CD Proparacaine Lidocaine Prilocaine Meprilcaine Dibucaine Dyclonine
m/z m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms m/z n.Rms
1348 1625 0.475 1565 0.599 1551 0.611 1566 0.695 1674 1 1620 —
1362 1639 0.551 1579 0.568 1565 0.622 1580 0.737 1688 1 1634 1.465
1376 1653 0.409 1593 0.614 1579 0.758 1594 0.836 1702 1 1648 1.336
1390 1667 0.620 1607 0.583 1593 0.715 1608 0.740 1716 1 1662 —
Average 0.513 0.591 0.677 0.752 1 1.401
RSDa 16.10 10.13 9.67 8.87 1 4.61
Note: not all data points were available due to the overlap of the signal. This is indicated by (—). All complex intensities values were normalized to
the responses from dibucaine.
aTo calculate RSD values, data from the three trials were considered.
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plexes with -CD had been reported [3, 25]. As
observed in this study, the presence of an additional
heterocyclic moiety in the anesthetic structure enhances
the binding with the -CD. This pattern was observed
from the relatively high K values for dibucaine and
dyclonine, which contain pyridine and piperidine rings
respectively. The correlation between the analyte–CD
complex behavior in the solution and the gas phases
was studied in two steps. First, the relative affinities of
the six compounds were compared to each CD, sepa-
rately. The decremental order of the values of associa-
tion constants as calculated from the CE were, dyclo-
nine, dibucaine, meprilcaine, prilocaine, lidocaine, and
proparacaine. The complexes intensities observed in the
ESI-MS for the different analytes decreased in the same
order as seen in the CE, as can be noticed from Table 1.
The second part was to study the effect of different
CD’s, by comparing the relative affinities of each ana-
lyte to three different CD’s. The general trend was that
the analytes have the greatest affinity for MCD and the
lowest for the heptakis-tri-methoxy--CD except for
meprilcaine and prilocaine, which have lower affinities
for MCD relative to heptakis di-methoxy--CD. This
trend, including the different meprilcaine and prilo-
caine behavior, could be observed from both the CE
data, as shown in Table 1, as well as the ESI-MS data, as
shown in Table 5. A cyclodextrin that has stronger
affinity to one analyte than to another, as expressed by
having higher K values in the CE experiments still gave
a more intense signal with that analyte in the ESI-MS.
Furthermore, the ESI-MS data shows that the interac-
tion of the analytes with the CD’s was not significantly
affected by the degree of substitutions on the CD’s. This
indicates that the association was due to interaction
with the CD cavity and that the number of the side
chains does not affect the access of the analyte to the CD
core. These correlations suggest that the complexes
detected in the ESI-MS experiments were passed intact
from the solution phase. Therefore these complexes are
believed to represent true specific inclusions rather than
false electrostatic adducts formed during the ionization
process. Due to the similarity of the behavior of these
complexes in the solution and the gas phases, it may be
possible to predict the CD selector that would produce
the best separation for a select set of compounds
depending on preliminary data obtained from the ESI-
MS. This approach would be of great advantage as
finding the correct CD as this is a time intensive process
and often requires a large quantity of expensive substi-
tuted CD’s.
Conclusion
This study suggests the formation of specific host–guest
inclusions between basic local anesthetics and CD’s, as
an extension to a former study done in this lab that
suggested the formation of specific complexes between
acidic barbiturates and CD’s [3]. We have shown a
direct correlation between the association constants of
six local anesthetics with three different CD’s as calcu-
lated from CE and the complexed fractions of the CD’s
as calculated from the ESI-MS, which suggests that
ESI-MS can be used to evaluate solution phase nonco-
valent complexes. The correlation indicates the possi-
bility of predicting the migration order and the behav-
ior of analyte–CD complexes based on the data
obtained from the MS. This information would make it
possible to predict the proper CD to use for a separation
based on quick screening of various CD’s using ESI-MS.
It is certain that ESI-MS could be used to eliminate CD’s
that showed poor affinity for an analyte and would
therefore, make a poor choice for further development
in a CE assay.
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aTo calculate RSD values, data from the three trials were considered.
Table 5. Normalized complex intensities values (n.Rms) of each
analyte with the 3 CD’s
MCD
Heptakis-di-o-
methyl--CD
Heptakis-tri-o-
methyl--CD
Proparacaine 12.23 8.12 1
Lidocaine 22.70 10.21 1
Prilocaine 4.23 4.71 1
Meprilcaine 7.95 8.10 1
Dibucaine 8.42 6.79 1
Dyclonine 2.73 2.41 1
Note: All complex intensities values were normalized to the responses
from heptakis-tri-o-methyl--CD.
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